RANI THERAPEUTICS HOLDINGS, INC. Debt Securities, Available-for-sale, Unrealized Loss
RANI THERAPEUTICS HOLDINGS, INC. (RANI) reported Debt Securities, Available-for-sale, Unrealized Loss of $39.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2026-08-13
- RANI THERAPEUTICS HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2026-06-30 was $27.00K.
- RANI THERAPEUTICS HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2026-03-31 was $12.00K, a 1100.00% increase year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2025-03-31 was $1.00K, a 96.30% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2024-12-31 was $0.00.
- RANI THERAPEUTICS HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- RANI THERAPEUTICS HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2023 was $28.00K, a 81.21% decline from fiscal 2022.
- RANI THERAPEUTICS HOLDINGS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2022 was $149.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month | Debt Securities, Available-for-sale, Unrealized Loss 6 month | Debt Securities, Available-for-sale, Unrealized Loss 9 month | Debt Securities, Available-for-sale, Unrealized Loss 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $39.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $12.00K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $3.00K 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | $1.00K 10-Q · filed 2025-05-13 | $1.00K derived: sum of 2 quarters · filed 2026-03-26 | -$14.00K derived: sum of 3 quarters · filed 2026-03-26 | -$26.00K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$15.00K derived: sum of 2 quarters · filed 2026-03-26 | -$27.00K derived: sum of 3 quarters · filed 2026-03-26 | $0.00 10-K · filed 2026-03-26 |
| 2024-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$27.00K derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $15.00K 10-Q · filed 2024-08-06 | ||
| 2024-03-31 | $27.00K 10-Q · filed 2024-05-06 | |||
| 2023-12-31 | $28.00K 10-K · filed 2025-03-31 | |||
| 2023-03-31 | $23.00K 10-Q · filed 2023-05-10 | $54.00K derived: sum of 2 quarters · filed 2024-03-20 | ||
| 2022-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $149.00K 10-K · filed 2024-03-20 | ||
| 2022-09-30 | $118.00K 10-Q · filed 2022-11-10 |